November 15, 2024
Yohei Hisada PhD awarded ISTH SSC small grant. The International Society on Thrombosis and Haemostasis (ISTH) is dedicated to transformative scientific discovery and standardized clinical practices, as well as the education of physicians, scientists and allied health professionals, globally. ISTH prioritizes this commitment by providing funding to support and advance innovative projects of the Scientific …
November 6, 2024
Alisa S. Wolberg, PhD presented the 2024 J. Evan Sadler Lectureship at Washington University in St. Louis. Her talk was entitled, “Venous Thrombosis and Factor XIII: Linking Biochemical Mechanisms to Novel Therapeutic Strategies”
November 6, 2024
Nigel Mackman PhD, John C. Parker Distinguished Professor of Medicine, gives keynote speech at University of Michigan Frankel Cardiovascular Center Symposium. On Monday September 23rd, Nigel Mackman gave his speech, “Mechanisms of Cancer- Associated Thrombosis and Bleeding: Focus on Tissue Factor- Positive Extracellular Vesicles” Read more here
October 31, 2024
November 2024 Newsletter
October 24, 2024
The publication entitled “Lessons Learned from the National Heart, Lung, and Blood Institute COVID-19 Clinical Trials” describes the process, barriers and successes in the rapid implementation of medical interventional clinical trials addressing morbidity and mortality related to the COVID-19 pandemic. Click here to read
September 20, 2024
Raj Kasthuri, MBBS, professor in the UNC Division of Hematology and director of the UNC HHT Center of Excellence, and a team of researchers published their study evaluating the safety and efficacy of pomalidomide for the treatment of Hereditary Hemorrhagic Telangiectasias in the New England Journal of Medicine. Hereditary Hemorrhagic Telangiectasias (HHT) is an inherited …
September 17, 2024
Yohei Hisada, Ph.D. was awarded an R56 from the NIH NHLBI in the amount of $764,817 for a one-year project titled “Mechanisms of Coagulopathy and Bleeding in Acute Promyelocytic Leukemia.” The award will fund studies to evaluate the hemorrhagic phenotype associated with hyperfibrinolysis in acute promyelocytic leukemia (APL), as well as the global changes in …
September 16, 2024
Nigel Key, MD was an invited plenary speaker at the French Congress on Hemostasis 2024 on September 12 in Lille, France. The title of his lecture was “Is tranexamic acid a universal hemostatic agent? What is left to learn about mechanism, dosing, timing, risks?” Website: https://www.congres-hemostase.com/
September 10, 2024
Abby Kordeliski has had the final version of her paper “4D intravital imaging studies identify platelets as the predominant cellular procoagulant surface in a mouse hemostasis model” published in Blood along with the cover image. Abby works in the Wolfgang Bergmeier laboratory in Mary Ellen Jones Building, Congratulations Abby! Cover image Link to the article that …
September 3, 2024
On August 23, 2024, we hosted our first seminar speaker of the Fall 2024 Semester, Dr. Mary Cushman from the University of Vermont. Dr. Cushman is the 2024 BRC Trainee Invited Speaker and her visit included a fantastic interactive workshop on how to write a research article, “Dialogue with a Recovering Editor” and a seminar …
August 20, 2024
Steven Grover, PhD has been awarded an R01 from NIH NHLBI in the amount of $3,275,000 for a five-year project titled “Regulation of Coagulation and Thrombosis by C1-inhibitor”. The award will fund translational studies to evaluate the procoagulant phenotype associated with congenital C1-inhibitor deficiency and the potential utility of FDA approved C1-inhibitor preparations as hemostasis …
August 2, 2024
August 2024 Newsletter